Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1432-1238
    Keywords: Key words Sepsis ; Hemostasis ; Organ failure ; Severity of disease ; IL-6 ; PAI-1 ; Neopterin
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Objective: To find out whether changes within the hemostatic system are related to the severity of illness and organ failure in patients at the onset of clinically defined sepsis and to find some indications for the contribution of endothelial cell activation or perturbation to the patient‘s status. The following measurements were undertaken: Acute Physiology and Chronic Health Evaluation (APACHE) II score, multiple organ failure (MOF) score, plasma levels of thrombin–antithrombin III complexes (TAT), antithrombin III (AT III), protein C antigen, factor XII, and plasminogen activator inhibitor type 1 antigen (PAI-1), neopterin, and interleukin 6 (IL-6). Design: A prospective case series study. Setting: Intensive care unit (ICU) of the Department of Internal Medicine, Justus Liebig University, Giessen, Germany. Patients: 28 consecutive patients (11 females, 17 males; mean age 58 years) with clinically defined sepsis. Eleven patients were admitted from the surgical ICU (9 after elective surgery, 2 after trauma surgery). The operations were done 1–26 days (mean 14 days) prior to the onset of sepsis. Main results: At the onset of sepsis we found elevated plasma levels of TAT, PAI-1, neopterin, and IL-6, and lowered plasma levels of AT III, factor XII, and protein Cantigen. Neopterin, PAI-1, IL-6, and factor XII showed a statistically significant correlation with the APACHE II score. The MOF score is significantly correlated with IL-6 and neopterin. The extent of hemostatic abnormalities was related to increasing levels of IL-6. Conclusions: Clinical evidence of a septic process is most likely to be preceded by activation of the hemostatic system, the vascular endothelium, and the monocyte/ macrophage system. IL-6 may have a regulatory function for hemostasis in inflammation. Laboratory monitoring could be helpful in deciding whether to start early intensive therapy in patients at risk for sepsis.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-1238
    Keywords: Sepsis ; Hemostasis ; Organ failure ; Severity of disease ; IL-6 ; PAI-1 ; Neopterin
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Objective To find out whether changes within the hemostatic system are related to the severity of illness and organ failure in patients at the onset of clinically defined sepsis and to find some indications for the contribution of endothelial cell activation or perturbation to the patient's status. The following measurements were undertaken: Acute Physiology and Chronic Health Evaluation (APACHE) II score, multiple organ failure (MOF) score, plasma levels of thrombin—antithrombin III complexes (TAT), antithrombin III (AT III), protein C antigen, factor XII, and plasminogen activator inhibitor type 1 antigen (PAI-1), neopterin, and interleukin 6 (IL-6). Design A prospective case series study. Setting Intensive care unit (ICU) of the Department of Internal Medicine, Justus Liebig University, Giessen, Germany. Patients 28 consecutive patients (11 females, 17 males; mean age 58 years) with clinically defined sepsis. Eleven patients were admitted from the surgical ICU (9 after elective surgery, 2 after trauma surgery). The operations were done 1–26 days (mean 14 days) prior to the onset of sepsis. Main results At the onset of sepsis we found elevated plasma levels of TAT, PAI-1, neopterin, and IL-6, and lowered plasma levels of AT III, factor XII, and protein Cantigen. Neopterin, PAI-1, IL-6, and factor XII showed a statistically significant correlation with the APACHE II score. The MOF score is significantly correlated with IL-6 and neopterin. The extent of hemostatic abnormalities was related to increasing levels of IL-6. Conclusions Clinical evidence of a septic process is most likely to be preceded by activation of the hemostatic system, the vascular endothelium, and the monocyte/macrophage system. IL-6 may have a regulatory function for hemostasis in inflammation. Laboratory monitoring could be helpful in deciding whether to start early intensive therapy in patients at risk for sepsis.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Springer
    Zeitschrift für Kardiologie 86 (1997), S. 320-326 
    ISSN: 1435-1285
    Keywords: Key words Atherectomy — angioplasty — controlled studies — restenosis rate ; Schlüsselwörter Atherektomie — Angioplastie — kontrollierte Studien — Restenoserate
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary Despite theoretical advantages of Directional Coronary Atherectomy (DCA) vs. PTCA, the first two controlled studies comparing both methods, the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT), and the Canadian Coronary Atherectomy Trial (CCAT), showed no clinical benefit of DCA. A second generation of trials, the Optimal Atherectomy Restenosis Study (OARS) and the Balloon versus Optimal Atherectomy Trial (BOAT), designed to optimize DCA with the use of 7F devices and adjunctive PTCA revealed lower angiographic restenosis rates compared to CAVEAT. In addition, the preliminary follow-up results of BOAT, presented by Donald S. Baim in Birmingham in August 1996, showed a 20% reduction of angiographic restenosis after DCA compared to PTCA. There was no association between post-procedure CK-MB elevation in the DCA group and late mortality. These results may further expand the application of DCA to clinical routine, whereas this procedure still has specific indications like treatment of ostial and bifurcation lesions and atherectomy in future may be the treatment of choice for restenosis in coronary stents.
    Notes: Zusammenfassung Trotz theoretischer Vorteile gegenüber der Ballondilatation zeigte sich im Langzeitverlauf nach direktionaler koronarer Atherektomie (DCA) bei der CAVEAT-(Coronary Angioplasty Versus Excisional Atherectomy Trial) und der CCAT-Studie (Canadian Coronary Atherectomy Trial) keine Reduktion der angiographischen Restenoserate. Eine zweite Generation kontrollierter Studien (Optimal Atherectomy Restenosis Study = OARS-Studie und Balloon versus Optimal Atherectomy Trial = BOAT-Studie), die mit der Zielsetzung konzipiert wurden, durch den häufigen Gebrauch von 7-F-Systemen und einer zusätzlichen PTCA eine "optimale" Atherektomie zu erreichen, zeigte gegenüber den Ergebnissen der CAVEAT-Studie ein deutlich besseres Langzeitergebnis. Nach den vorläufigen Daten von BOAT, die im August 1996 vorgestellt wurden und ca. 75% der Langzeitergebnisse des Gesamtkollektivs beinhalten, wurde die Restenoserate gegenüber der PTCA um 20% gesenkt. Die nach DCA beobachtete Erhöhung der myokardspezifischen Kreatininphosphokinase war nicht mit einer erhöhten Mortalität assoziiert. Neben der nachgewiesenen klinischen Wirksamkeit der DCA haben sich spezielle Indikationen wie Ostium- und Bifurkationsstenosen herausgestellt. Die DCA stellt wahrscheinlich auch in der Behandlung von Restenosen in Stents eine gute Alternative dar.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...